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Resistin is an adipokine that induces insulin resistance in mice. In humans, resistin is 
not produced in adipocytes, but in various leukocytes instead, and it acts as a 
pro-inflammatory molecule. The present investigation demonstrated high levels of 
resistin in culture supernatants of neutrophils that are stimulated by a highly leukotoxic 
strain of Aggregatibacter actinomycetemcomitans. In contrast, the level of resistin was 
remarkably low when neutrophils were exposed to two other strains that produce 
minimal levels of leukotoxin and a further isogenic mutant strain incapable of 
producing leukotoxin. Pretreatment of neutrophils with a monoclonal antibody to CD18, 
β chain of LFA-1, or a Src family tyrosine kinase inhibitor prior to incubation with the 
highly leukotoxic strain inhibited the release of resistin. These results show that A. 
actinomycetemcomitans-expressed leukotoxin induces extracellular release of human 
neutrophil-derived resistin by interacting with LFA-1 on the surface of neutrophils and, 
consequently, activating Src family tyrosine kinases. 
 
 









Resistin is one of several adipokines expressed in the adipose tissue of mice (Steppan, et 
al., 2001). In humans, resistin is expressed at very low levels in adipocytes and at higher 
levels in white blood cells (Savage, et al., 2001). Circulating levels of resistin are 
elevated in patients with acute and chronic diseases, including cardiovascular disease, 
atherosclerosis, rheumatoid arthritis, and type 2 diabetes (Migita, et al., 2006, Takeishi, 
et al., 2007, Shin, et al., 2008, Chen, et al., 2009). Increased circulating levels of 
resistin are also observed in patients with periodontitis (Furugen, et al., 2008, Saito, et 
al., 2008). An increased serum resistin level has been epidemiologically linked with 
various diseases in humans that involve inflammation.   
 
It was recently reported that human neutrophils store abundant amounts of resistin in 
granules, which is released extracellularly upon inflammatory stimulation by bacteria, 
such as Streptococcus pyogenes and Escherichia coli, or by selected bacterial 
components, such as streptococcal M protein and N-formyl-Met-Leu-Phe (fMLP) 
(Bostrom, et al., 2009, Johansson, et al., 2009, Kunnari, et al., 2009).   
 
Aggregatibacter (Actinobacillus) actinomycetemcomitans, a Gram-negative facultative 
anaerobic coccobacillus, has been implicated in periodontal diseases, especially 
aggressive periodontitis, and other infectious diseases, such as endocarditis (Zambon, 
1985, Paturel, et al., 2004, Haubek, et al., 2008). It expresses several potential virulence 
factors thought to play roles in the modulation of inflammation, induction of tissue 




Leukotoxin, a virulence factor from A. actinomycetemcomitans interacts with 
lymphocyte function-associated molecule 1 (LFA-1), which is a β2 integrin expressed 
on mammalian cells, and exhibits cytolytic activity towards polymorphonuclear 
leukocytes (PMNs) and macrophages of humans and primates (Taichman, et al., 1980, 
Taichman, et al., 1987). Furthermore, leukotoxin has been reported to induce 
degranulation of PMNs independent of LFA-1 (Johansson, et al., 2000). In this study, 
we examined whether neutrophil-derived resistin was released extracellularly by 
stimulation with several A. actinomycetemcomitans strains that express differing levels 
of leukotoxin and whether it was released by cytolysis or degranulation.  
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MATERIALS AND METHODS 
 
Bacterial strains and culture conditions  
 
Aggregatibacter actinomycetemcomitans HK921 (strain JP2), HK912 and HK1604, 
which are minimally leukotoxic strains, were grown in brain heart infusion broth (BHI; 
Difco Laboratories) at 37°C in air plus 5% CO2. The three strains were a gift from Prof. 
Mogens Kilian, Department of Medical Microbiology and Immunology, Aarhus 
University, Aarhus, Denmark. Escherichia coli strains were grown in Luria-Bertani 
medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl) at 37°C with aeration. When 
necessary for the selection of recombinant strains, the medium was supplemented with 
ampicillin (100 mg/L) and/or kanamycin (25 mg /L). 
 
Generation of an ltxA-disrupted HK921 strain  
 
The ltxA gene was inactivated in the HK921 strain by insertional mutagenesis as 
described previously (Hayashida, et al., 2002). Briefly, a fragment of the ltxA gene 
(positions 615 to 2,978 in the open reading frame of ltxA from strain HK921) was 
amplified from 1 ng of whole-cell DNA by PCR using the following primers:  
5'-ACAACTTAATAAGTTAGGTGAAGCAC-3' (615 to 640)  
and 5'-GACTTACCTTTATTCTTAATAAGTC-3' (2,954 to 2,978).  
The amplicon was cloned into pGEM-T Easy Vector (Promega) using E. coli XL-1 Blue 
for propagation. The resulting plasmid was termed “pGEM-ltxA.” The kanamycin 
resistance gene from the 1.7-kb transprimer transposon in pGPS1.1 was inserted into the 
ltxA gene fragment in pGEM-ltxA using TnsABC transposase. The purified plasmid was 
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introduced into A. actinomycetemcomitans by electroporation, and the cells were plated 
onto BHI agar containing kanamycin to select for transformants. 
 
SDS-PAGE and Western blot analysis 
 
After overnight incubation in BHI broth, the bacteria were harvested by centrifugation 
at 16,000 × g for 2 min. Bacterial pellets were resuspended in 100 µL of SDS sample 
buffer and boiled for 5 min. Samples (10 µL) were loaded onto a 10% polyacrylamide 
gel with a 4.5% polyacrylamide stacking gel and electrophoresed at 20 mA until the dye 
front was at the end of the gel. The protein bands were stained using a Rapid Stain CBB 
Kit (Nacalai Tesque, Japan). 
For Western blot analysis, proteins were transferred from the polyacrylamide gel to a 
PVDF membrane (Millipore). The membrane was incubated with rabbit antiserum 
against A. actinomycetemcomitans leukotoxin (1:10,000 dilution), followed by 
incubation with horseradish peroxidase-conjugated anti-rabbit immunoglobulin 
(1:10,000 dilution; Sigma-Aldrich). After incubation, immunoreactive proteins were 
visualized using the ECL Plus Western blotting detection reagent (Amersham 
Biosciences). 
 
Preparation of human neutrophils 
 
Human neutrophils were isolated from blood collected from healthy volunteers, and 
blood cell fractions were separated using Mono-Poly Resolving Medium (DS Pharma 
Biomedical) according to the manufacturer’s instructions. Anti-CD16-coupled MACS 
MicroBeads (Miltenyi Biotec K.K.) were used to separate the neutrophils from the 
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samples. The cells were used immediately for the culture experiments. The neutrophils 
were assessed morphologically by phase-contrast microscopy and were shown to be 
>99% viable as determined by Trypan blue exclusion. 
 
The healthy volunteers were informed about the purpose of the study and gave written 
consent before blood samples were taken. The study was approved by the Ethics 
Committee of the Nagasaki University Graduate School of Biomedical Sciences.  
 
Exposure of human neutrophils to bacterial cells of A. actinomycetemcomitans 
strains 
 
Aggregatibacter actinomycetemcomitans strains were incubated overnight at 37°C in air 
plus 5% CO2. The bacteria were collected by centrifugation, mixed with human 
neutrophils (1×106/mL) in RPMI-1640 with 1% fetal calf serum, and incubated at 37°C 
in air plus 5% CO2. First, to examine the dose-dependent release of resistin and to 
determine optimum bacterial stimulation for subsequent experiments, we incubated 
neutrophils with bacteria at different relative ratios. Second, to examine the effect of 
leukotoxin promoter type on the level of resistin released, we incubated neutrophils with 
bacteria at a relative ratio of 1:1000 HK921, HK912, or HK1604 cells. Third, to 
examine whether leukotoxin expression affected the level of resistin release and how the 
level of resistin was related to degranulation and cytolysis, we incubated neutrophils 
with HK921 or its mutant, which was incapable of producing leukotoxin. Fourth, to 
examine the involvement of the leukotoxin receptor LFA-1 and a Src family tyrosine 
kinase, we used mouse monoclonal antibodies against LFA-1 subunits, TS1/22 
(Endogen), recognizing CD11a, and TS1/18 (Endogen), recognizing CD18, and the Src 
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family tyrosine kinase inhibitor PP1 (Calbiochem). Neutrophils were preincubated with 
monoclonal antibodies (5 μg/mL) or PP1 (10 μM) for 15 min. Culture supernatants were 
collected after 0.5, 2, and 4 h of incubation in these experiments. 
 
Measurements of human resistin and elastase released from human neutrophils 
 
Concentrations of resistin and elastase in the sample supernatants were measured by 
ELISA (R&D Systems and Hycult Biotech, respectively). Cell-free supernatants were 
diluted in dilution buffer at a ratio of 1:10 for resistin and 1:20 for elastase 
measurements. Both resistin and elastase were quantified with reference to a standard 
curve generated by serial dilution of recombinant proteins provided by the 
manufacturer. The lower limit of detection was pg/mL for resistin and ng/mL for 
elastase. Relative release of elastase is expressed as a percentage of the total elastase 
obtained by lysing the cells with 0.1% Triton X-100 (Promega) for 1 h. All samples 
were measured in duplicate. 
 
Cytolysis assay  
 
The level of cytolysis was determined by the amount of the cytosolic enzyme lactate 
dehydrogenase (LDH) that was released, as measured using an LDH detection kit 
(Takara) according to the manufacturer’s instructions. Relative cytolysis is expressed as 
a percentage of the total LDH activity obtained by lysing the cells with 0.1% Triton 
X-100 for 1 h. 






Data are presented as the means ± standard deviation. Student’s t-test was used for 
comparisons between two groups. One-way analysis of variance (ANOVA) was used to 
test whether the means of three groups were equal. When there was a statistical 
difference in ANOVA, post hoc comparisons were assessed using Scheffe’s test or 
Dunnett's test for multiple comparisons, as appropriate. Differences were considered 






Dose response relationship between the ratio of bacteria to neutrophils and the 
level of resistin released 
 
The amount of resistin in the supernatant of the neutrophils incubated with HK 921 
increased significantly with an increase in the ratio of bacteria to neutrophils in a 
dose-dependent manner (Fig. 1). The ratio of 1000 bacteria per neutrophil was used in 
subsequent experiments. 
 
Difference in resistin release between exposure to highly leukotoxic and minimally 
leukotoxic strains 
 
The amounts of resistin and elastase in the supernatant of the neutrophils incubated with 
HK921 for 2 h or longer were significantly higher than those with the two minimally 
leukotoxic strains, HK912 and HK1604 (Fig. 2A and B). 
 
Insertional inactivation of the leukotoxin gene 
 
Leukotoxin was detected on Western blots of protein samples from the wild-type 
HK921 strain using rabbit antiserum against A. actinomycetemcomitans leukotoxin. No 
leukotoxin was detected in the HK921 strain with an insertional mutation of the ltxA 




Simultaneous leukotoxin-induced release of resistin and elastase from neutrophils 
before cytolysis 
  
We measured the resistin, elastase, and LDH released from neutrophils after stimulation 
with the wild-type and mutant HK921 strains for 0.5, 2, and 4 h. The resistin level in the 
supernatant of the neutrophils incubated with wild-type HK921 was significantly higher 
than the level after incubation with the mutant strain (Fig. 4A). The level of elastase 
after incubation with wild-type HK921 for 2 h was nearly 75% of that after 4 h of 
incubation, but cytolysis was markedly lower after 2 h than after 4 h (Fig. 4B and C). 
These results suggest that A. actinomycetemcomitans-expressed leukotoxin induced the 
release of resistin by degranulation of the neutrophils prior to cytolysis.  
 
Effect of monoclonal antibodies against LFA-1 subunits and a Src family tyrosine 
kinase inhibitor on the release of resistin and elastase 
 
To examine the possible involvement of LFA-1, which is the receptor for leukotoxin, 
and a Src family tyrosine kinase in the release of resistin and elastase, we pretreated 
neutrophils with monoclonal TS1/22 (CD11a) or TS1/18 (CD18) antibody against 
LFA-1 subunits at a final concentration of 5 μg/mL and with 10 μM PP1 for 15 min, 
followed by incubation with wild-type or mutant HK921 for 2 h (Fig. 5A and B). In 
contrast to pretreatment with TS1/22, the level of resistin released from neutrophils 
pretreated with TS1/18 or PP1 was significantly lower than that from untreated 
neutrophils after incubation with wild-type HK921, as was the release of elastase. 
Additionally, the inhibitory effect of pretreatment with TS1/18 or PP1 on the levels of 
resistin and elastase released from neutrophils after incubation with mutant HK921 for  
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Among the several virulence factors expressed by A. actinomycetemcomitans, 
leukotoxin is thought to play a major role in disease progression (Henderson, et al., 
2003). Leukotoxin has been reported to activate cytolysis of human leukocytes, 
including neutrophils and monocytes (Taichman, et al., 1980), and to induce caspase-1 
activation and bio-active IL-1β secretion in human macrophages (Kelk, et al., 2003). In 
the present study, significantly more resistin was released from neutrophils incubated 
with wild-type HK921, which is characterized by a 530-bp deletion of the promoter 
region of the leukotoxin gene, than from neutrophils incubated with minimally 
leukotoxic strains. The ability of the wild-type strain to produce leukotoxin was 
confirmed by Western blot analysis using a leukotoxin-specific antiserum, and its 
cytotoxic activity against neutrophils was demonstrated by LDH release. Furthermore, 
the mutant strain, which is incapable of producing leukotoxin, released a significantly 
lower level of resistin (P < 0.05).  
 
Whereas resistin is derived exclusively from adipose tissue in mice, leukocytes are the 
major source of resistin in humans. Neutrophils store abundant amounts of resistin in 
their granules, and the extracellular release of resistin via degranulation may be 
stimulated by bacterial or inflammatory stimuli (Bostrom, et al., 2009, Johansson, et al., 
2009, Kunnari, et al., 2009). 
 
This study demonstrated the release of resistin from neutrophils in the presence of a 
highly leukotoxic strain, which is strongly associated with aggressive periodontitis in 
certain susceptible human populations (Haubek, et al., 2008), was significantly higher 
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than in the presence of a leukotoxin-deficient isogenic mutant (P < 0.05). Based on this 
result, the release induced by the wild-type strain was attributed to an effect of 
leukotoxin.  
  
These observations, combined with the above-mentioned demonstrations of human 
resistin storage in neutrophil granules and resistin release in response to microbial 
stimuli, indicate that neutrophil granules were the source of the resistin released in our 
study. This conclusion is supported by the simultaneous release of resistin and 
granule-associated elastase (Fig. 4A and B). We have little information on how 
degranulation of neutrophils is stimulated by leukotoxin. Johansson et al. (2000) 
reported that leukotoxin induced degranulation of PMNs and that the polyclonal 
antibodies against LFA-1 subunits had no effect on degranulation. Moreover, signals 
involved in triggering degranulation by neutrophils stimulated by leukotoxin are poorly 
understood. 
 
Integrins, which are heterodimeric transmembrane adhesion receptors localized at 
cell–matrix contact sites, link extracellular matrix components to the actin cytoskeleton 
and interact with multiple structural and signaling molecules. LFA-1, a member of the 
β2-integin family, including CD11a and CD18, is a leukotoxin receptor located on the 
surface of neutrophils (Lally, et al., 1997). The significant decrease in 
leukotoxin-induced resistin release from neutrophils pretreated with TS1/18 in the 
present study provides evidence for the involvement of CD18 in resistin release (Fig. 
5A), as a recent study reported that CD18 is essential for the biological effect induced 
by leukotoxin (Dileepan, et al., 2007). Our results differ from those reported by 
Johansson et al. (2000), and we cannot completely explain the discrepancy. It is possible 
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the polyclonal antibodies used by Johannson et al. (2000) were less effective than the 
monoclonal antibodies that we used in the inhibition study. 
 
Furthermore, the inhibition of leukotoxin-induced resistin release from neutrophils 
incubated with PP1 indicates that a Src family tyrosine kinase participates in resistin 
release (Fig. 5A). Src family tyrosine kinases have been reported to be important 
mediators acting downstream of integrins to effect adhesion-dependent degranulation of 
neutrophils (Mocsai, et al., 1999). Although PP1 inhibited adhesion-dependent 
degranulation, it had no effect on adhesion-independent degranulation induced by 
phorbol 12-myristate 13-acetate. 
 
The results obtained from experiments with TS1/18 and PP1 suggest that leukotoxin 
binds to LFA-1 on the surface of neutrophils and then activates a Src family tyrosine 
kinase, leading to the release of resistin from neutrophils by degranulation, as well as 
adhesion-dependent degranulation. 
 
Release of resistin and elastase still occurred, but a lower level, when stimulated by the 
mutant strain (Fig. 4). Moreover, pretreatment with TS1/18 or PP1 inhibited release of 
resistin and elastase from neutrophils stimulated by the mutant strain (Fig. 5A and B). 
Another molecule of A. actinomycetemcomitans might interact with CD18. Previous 
studies have reported that the CD18 of other β2 integrins, such as Mac-1 
(CD11b/CD18) and p150/95 (CD11c/CD18), interacts with lipopolysaccharide (LPS) 
and induces a cellular response (Ingalls & Golenbock, 1995, Flaherty, et al., 1997, 
Wong, et al., 2007). Therefore, LPS of A. actinomycetemcomitans might interact with 
CD18 of Mac-1 and p150/95 and lead to the release of resistin via degranulation. 
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Further study is needed to clarify the details.  
 
β2 integrins reportedly must be activated to interact with their ligands (Abram & 
Lowell, 2009). The possible reason why neutrophil degranulation in the present study 
was slower than expected might be that the priming agents, such as chemokines and 
chemoattractants, in the culture medium were insufficient in quantitative and qualitative 
aspects to rapidly activate resting neutrophils freshly isolated from the blood. Therefore, 
most of the β2 integrins might have been in inactive form for some time and could not 
easily interact with their ligands. 
 
Aggregatibacter actinomycetemcomitans has been detected in atherosclerotic lesions, 
suggesting that it may be associated with the development and progression of the 
condition (Haraszthy, et al., 2000). An effect of resistin on endothelium-related 
atherosclerotic events was indicated by a reported dose-dependent increase in monocyte 
adhesion to endothelial cells after resistin exposure, an effect likely to be attributable to 
the upregulation of two adhesion molecules, monocyte chemotactic protein-1 and 
platelet/endothelial cell adhesion molecule-1 (Kunnari, et al., 2009). Thus, A. 
actinomycetemcomitans may play a role in the development and progression of 
atherosclerosis through the release of resistin from neutrophils in or surrounding the 
atherosclerotic lesion. 
 
The results presented have provided some insight into the relationship between 
neutrophil-derived resistin and A. actinomycetemcomitans. Although the present results 
do not directly establish a relationship between circulating resistin and periodontitis, the 
observations suggest that increased prevalence and levels of A. actinomycetemcomitans 
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in periodontal patients contribute to their higher circulating levels of resistin. 
Clarification of the importance of resistin release induced by periodontal bacteria in the 
pathogenesis of atherosclerosis, as well as the contribution of resistin release to 
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Figure 1. Release of resistin from human neutrophils induced by the A. 
actinomycetemcomitans HK921 wild-type strain at relative ratios of 0, 10, 100, and 
1000 bacteria/neutrophil. Neutrophils were incubated with bacteria for 0.5, 2, and 4 h. 
Scheffe’s test was used for multiple comparisons. * P < 0.05 compared with all other 
groups. Data are representative of two independent experiments (n=3). Error bars 






Figure 2. Release of resistin 
from human neutrophils 
induced by strains HK921, 
HK912, and HK1604 at a 
relative ratio of 1000 
bacteria/neutrophil. 
Neutrophils were incubated 
with bacteria for 0.5, 2, and 4 
h. Control shows results of 
neutrophils incubated without 
bacteria as a negative control 
(cont.). (A) Release of 
resistin, (B) percentage of 
elastase release, and (C) 
percentage of cytolysis. 
Scheffe’s test was used for 
multiple comparisons. * P < 
0.05 compared with HK921. 
Data are representative of two 
independent experiments 







Figure 3. Western blot analysis using anti-leukotoxin antibody to detect leukotoxin 
production by A. actinomycetemcomitans strain HK921. Lane 1, wild-type HK921 





Figure 4. Release of resistin and 
elastase from human neutrophils and 
cytolysis induced by the A. 
actinomycetemcomitans HK921 
wild-type strain (HK921) and the 
mutant strain unable to produce 
leukotoxin (MT). Neutrophils were 
incubated with bacteria for 0.5, 2, and 4 
h. Control shows results of neutrophils 
incubated without bacteria as a negative 
control (cont.). (A) Release of resistin, 
(B) percentage of elastase release, and 
(C) percentage of cytolysis. Student’s 
t-test was used for comparison between 
HK921 and MT. * P < 0.05 compared 
with HK921. Data are representative of 
three independent experiments (n=3). 
Error bars represent standard 




Figure 5. Effect of antibodies to LFA-1 subunits and PP1 on the release of resistin from 
neutrophils. (A) Release of resistin, (B) percentage of elastase release. Neutrophils were 
preincubated with monoclonal antibodies (5 μg/mL) or PP1 (10 μM) for 15 min and 
then incubated with bacteria for 0.5, 2, and 4 h. Control shows results of neutrophils 
incubated without bacteria as a negative control (cont.). Dunnett’s test was used to 
compare untreated and treated neutrophils. * P < 0.05 compared with untreated. Data 
are representative of two independent experiments (n=3). Error bars represent standard 
deviations. 
